Hedge Fund and Insider Trading News: Carl Icahn, SkyBridge Capital, Xeris Pharmaceuticals Inc (XERS), Legacy Reserves LP Unit (LGCY), Pershing Gold Corp (PGLC), and More

Page 2 of 2

Insider Buying: Xeris Pharmaceuticals Inc (XERS) Major Shareholder Buys 150,000 Shares of Stock (MaconDaily.com)
Xeris Pharmaceuticals Inc (NASDAQ:XERS) major shareholder Palmetto Partners, Ltd. purchased 150,000 shares of the stock in a transaction dated Monday, June 25th. The shares were bought at an average cost of $15.00 per share, for a total transaction of $2,250,000.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission.

Insider Buying: Resonant Inc (RESN) Director Acquires 100,000 Shares of Stock (TheLincolnianOnline.com)
Resonant Inc (NASDAQ:RESN) Director Michael J. Fox purchased 100,000 shares of the business’s stock in a transaction dated Friday, June 15th. The stock was bought at an average price of $5.61 per share, for a total transaction of $561,000.00. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Insider Buying: Legacy Reserves LP Unit (LGCY) Major Shareholder Acquires 74,076 Shares of Stock (TheEnterpriseLeader.com)
Legacy Reserves LP Unit (NASDAQ:LGCY) major shareholder Baines Creek Capital, Llc bought 74,076 shares of the firm’s stock in a transaction on Friday, June 15th. The stock was acquired at an average cost of $6.00 per share, with a total value of $444,456.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission.

Insider Buying: Pershing Gold Corp (PGLC) Director Acquires 125,000 Shares of Stock (TheLincolnianOnline.com)
Pershing Gold Corp (NASDAQ:PGLC) Director Barry C. Honig bought 125,000 shares of the company’s stock in a transaction on Friday, June 15th. The shares were acquired at an average price of $2.00 per share, for a total transaction of $250,000.00. Following the transaction, the director now directly owns 2,395,600 shares in the company, valued at approximately $4,791,200. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Insider Buying: Electrocore LLC (ECOR) Major Shareholder Purchases 166,666 Shares of Stock (MareaInformativa.com)
Electrocore LLC (NASDAQ:ECOR) major shareholder Global Health Innovation Merck purchased 166,666 shares of the business’s stock in a transaction that occurred on Thursday, June 21st. The shares were purchased at an average cost of $15.00 per share, with a total value of $2,499,990.00. The transaction was disclosed in a filing with the Securities & Exchange Commission.






Page 2 of 2